Genus plc (LON: GNS)
London
· Delayed Price · Currency is GBP · Price in GBX1,644.00
-42.00 (-2.49%)
Nov 21, 2024, 5:04 PM BST
Genus Revenue
In the fiscal year ending June 30, 2024, Genus had annual revenue of 668.80M GBP, down -3.03%. Genus had revenue of 335.20M in the half year ending June 30, 2024, with 7.37% growth.
Revenue
668.80M
Revenue Growth
-3.03%
P/S Ratio
1.66
Revenue / Employee
191.09K
Employees
3,500
Market Cap
1.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 668.80M | -20.90M | -3.03% |
| Jun 30, 2023 | 689.70M | 96.30M | 16.23% |
| Jun 30, 2022 | 593.40M | 19.10M | 3.33% |
| Jun 30, 2021 | 574.30M | 22.90M | 4.15% |
| Jun 30, 2020 | 551.40M | 62.90M | 12.88% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 38.20B |
| GSK plc | 31.31B |
| Haleon plc | 11.24B |
| Smith & Nephew plc | 4.46B |
| ConvaTec Group PLC | 1.74B |
| Hikma Pharmaceuticals PLC | 2.39B |
| Oxford Nanopore Technologies plc | 167.75M |
| Animalcare Group plc | 76.10M |
Genus News
- 2 months ago - GNS cuts in NZ could ‘devastate’ critical work according to 85 international scientists that study risks from tsunami, earthquakes, disasters - NZ Herald
- 2 months ago - Why Is Nano Nuclear Stock Jumping Today? - Benzinga
- 2 months ago - Genus PLC (GENSF) (Q4 2024) Earnings Call Transcript Highlights: Strong Porcine Growth Amid ... - GuruFocus
- 2 months ago - Genus plc (GENSF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Full Year 2024 Genus PLC Earnings Call Transcript - GuruFocus